磁共振T1w/T2w比值:一种简约的帕金森病标志物
本研究用磁共振T1w/T2w比值研究76例帕金森病患者和70例对照,发现患者黑质致密部T1w/T2w比值升高,鉴别帕金森病与对照的敏感度0.908、特异度0.80(AUC=0.926),早期患者AUC=0.901,并在第二独立队列(73例患者、49例对照)中验证。
要点
- 帕金森病患者黑质致密部T1w/T2w比值较对照升高。
- 该比值鉴别帕金森病与对照的敏感度0.908、特异度0.80(AUC=0.926)。
- 病程≤2年的早期患者AUC=0.901,敏感度0.857、特异度0.857。
核心结论
- T1w/T2w比值可检测帕金森病相关的黑质致密部改变,可能作为该病的新型、简约在体生物标志物,尤其适用于早期患者,具有较高的临床与研究转化价值。
研究设计与样本
- 研究纳入76例帕金森病患者和70例对照,采用体素分析和感兴趣区方法分析归一化空间中的T1w/T2w比值图,并评估黑质致密部比值的敏感度和特异度。
- 另设第二独立队列(73例帕金森病患者、49例对照)用于验证。
主要发现
- 与对照相比,帕金森病患者右侧中脑(簇大小=164mm3,p<0.0001)和左侧中脑(簇大小=213mm3,p<0.0001)T1w/T2w比值升高,位于红核腹外侧、对应黑质致密部。
- 感兴趣区方法证实帕金森病与对照的黑质致密部T1w/T2w比值差异(p<0.0001)。
- 黑质致密部T1w/T2w比值区分帕金森病与对照的敏感度为0.908、特异度为0.80(AUC=0.926);病程≤2年的早期患者AUC=0.901、敏感度=0.857、特异度=0.857。
- 上述结果在第二队列中得到验证。
临床怎么用
- 作者认为T1w/T2w比值可能作为帕金森病的新型、简约在体生物标志物,尤其适用于早期患者,具有较高的临床与研究转化价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Newer magnetic resonance imaging (MRI) techniques have shown promise in capturing early Parkinson disease (PD)-related changes in the substantia nigra pars compacta (SNc), the key pathological loci. Their translational value, however, is hindered by technical complexity and inconsistent results. METHODS: A novel yet simple MRI contrast, the T1w/T2w ratio, was used to study 76 PD patients and 70 controls. The T1w/T2w ratio maps were analyzed using both voxel-based and region-of-interest approaches in normalized space. The sensitivity and specificity of the SNc T1w/T2w ratio in discriminating between PD and controls also were assessed. In addition, its diagnostic performance was tested in a subgroup of PD patients with disease duration ≤2 years (PDE). A second independent cohort of 73 PD patients and 49 controls was used for validation. RESULTS: Compared to controls, PD patients showed a higher T1w/T2w ratio in both the right (cluster size = 164mm3 , p < 0.0001) and left (cluster size = 213mm3 , p < 0.0001) midbrain that was located ventrolateral to the red nucleus and corresponded to the SNc. The region-of-interest approach confirmed the group difference in the SNc T1w/T2w ratio between PD and controls (p < 0.0001). The SNc T1w/T2w ratio had high sensitivity (0.908) and specificity (0.80) to separate PD and controls (area under the curve [AUC] = 0.926), even for PDE patients (AUC = 0.901, sensitivity = 0.857, specificity = 0.857). These results were validated in the second cohort. INTERPRETATION: The T1w/T2w ratio can detect PD-related changes in the SNc and may be used as a novel, parsimonious in vivo biomarker for the disease, particularly for early stage patients, with high translational value for clinical practice and research. ANN NEUROL 2019;85:96-104.
引用
- Du G, Lewis MM, Sica C, et al. Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson disease. Ann Neurol. 2018. PMID: 30408230. doi:10.1002/ana.25376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。